{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:17:32Z","timestamp":1769595452978,"version":"3.49.0"},"reference-count":10,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"HHS | NIH | National Cancer Institute (NCI)","award":["CA192613"],"award-info":[{"award-number":["CA192613"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Cancer Biology & Therapy"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1080\/15384047.2017.1394556","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T11:09:02Z","timestamp":1512731342000},"page":"132-137","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":27,"title":["The levels of mutant K-RAS and mutant N-RAS are rapidly reduced in a Beclin1 \/ ATG5 -dependent fashion by the irreversible ERBB1\/2\/4 inhibitor neratinib"],"prefix":"10.1080","volume":"19","author":[{"given":"Laurence","family":"Booth","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane L.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Poklepovic","sequence":"additional","affiliation":[{"name":"Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kirkwood","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Cancer Institute, Melanoma and Skin Cancer Program, Hillman Cancer Research Pavilion Laboratory L1.32c, Pittsburgh, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4136-1342","authenticated-orcid":false,"given":"Cindy","family":"Sander","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Cancer Institute, Melanoma and Skin Cancer Program, Hillman Cancer Research Pavilion Laboratory L1.32c, Pittsburgh, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Avogadri-Connors","sequence":"additional","affiliation":[{"name":"Puma Biotechnology Inc. 1880 Wilshire Blvd, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Cutler Jr","sequence":"additional","affiliation":[{"name":"Puma Biotechnology Inc. 1880 Wilshire Blvd, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alshad S.","family":"Lalani","sequence":"additional","affiliation":[{"name":"Puma Biotechnology Inc. 1880 Wilshire Blvd, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dent","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7746"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9040027"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00283"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.02.025"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21660"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.08.026"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M047654"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006257"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2662"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.7.4.5543"}],"container-title":["Cancer Biology & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15384047.2017.1394556","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15384047.2017.1394556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T07:47:29Z","timestamp":1556783249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15384047.2017.1394556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,2]]},"published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1080\/15384047.2017.1394556"],"URL":"https:\/\/doi.org\/10.1080\/15384047.2017.1394556","relation":{},"ISSN":["1538-4047","1555-8576"],"issn-type":[{"value":"1538-4047","type":"print"},{"value":"1555-8576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kcbt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kcbt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}